Glucose transporter and folic acid receptor-mediated Pluronic P105 polymeric micelles loaded with doxorubicin for brain tumor treating
Authors:
- 7 May 2014
- journal article
- research article
- Published by Taylor & Francis in Journal of Drug Targeting
- Vol. 22 (8) , 712-723
Abstract
In this study, glucose transporter and folic acid (FA) receptor-mediated Pluronic P105 polymeric micelles loaded with DOX (GF-DOX) were prepared for enhancing the blood–brain barrier (BBB) transportation and improving the drug accumulation in the glioma cells. The pH-triggered DOX release of GF-DOX indicating a comparatively fast drug release at weak acidic condition and stable state of the carrier at physiological environment. The transport of GF-DOX across the in vitro BBB model showed that GF-DOX exhibited higher BBB transportation ability with the transporting ratio of 21.47% in 4 h. The carrier was internalized into C6 glioma cells upon crossing the BBB model for the combined effect of the brain targeting by transportation of glucose transporter and active tumor cell targeting by FA receptor-mediated endocytosis. Moreover, minimized weight changes and high suppression ratio of tumor growth were observed after intravenous injection of GF-DOX. In conclusion, the glucose transporter and FA dual-targeting micelles would provide a safe and effective strategy for new modalities to treat brain tumor.Keywords
This publication has 41 references indexed in Scilit:
- Active Drug Targeting of Disease by Nanoparticles Functionalized with Ligand to Folate ReceptorCurrent Medicinal Chemistry, 2012
- Gold nanoparticles as a contrast agent forin vivotumor imaging with photoacoustic tomographyNanotechnology, 2009
- Folate-mediated chondroitin sulfate-Pluronic® 127 nanogels as a drug carrierEuropean Journal of Pharmaceutical Sciences, 2009
- Drug Transport Across the Blood-Brain Barrier and the Impact of Breast Cancer Resistance Protein (ABCG2)Current Topics in Medicinal Chemistry, 2009
- Prevention of MDR development in leukemia cells by micelle-forming polymeric surfactantJournal of Controlled Release, 2008
- Pluronic block copolymers: Evolution of drug delivery concept from inert nanocarriers to biological response modifiersJournal of Controlled Release, 2008
- Drug Targeting to the BrainPharmaceutical Research, 2007
- Poly(ethylene oxide)–poly(propylene oxide) block copolymer micelles as drug delivery agents: Improved hydrosolubility, stability and bioavailability of drugsEuropean Journal of Pharmaceutics and Biopharmaceutics, 2007
- Pluronic block copolymers alter apoptotic signal transduction of doxorubicin in drug-resistant cancer cellsJournal of Controlled Release, 2005
- Tumor targeting based on the effect of enhanced permeability and retention (EPR) and the mechanism of receptor-mediated endocytosis (RME)International Journal of Pharmaceutics, 2004